• Angiotensin I/II (1-5): Evidence Scope

  2026-10-11

  APExBIO lists Angiotensin I/II (1-5) as the Asp-Arg-Val-Tyr-Ile pentapeptide, a short fragment associated by the supplier with renin–angiotensin system research. No matched research paper was provided, so its documented identity and intended conceptual scope can be described, but biological activity, mechanism, comparative performance, and research outcomes cannot be independently established here.

• Tropisetron and Renal OCT2/MATE1 Inhibition

  2026-10-10

  George et al. systematically compared five 5-HT3 antagonists for inhibition of the renal organic cation transporters OCT2 and MATE1, identifying distinct transporter-specific potency patterns and evidence of reduced transcellular secretion in cell models. The findings position tropisetron within a broader drug–transporter interaction framework, while remaining preliminary because the study was conducted entirely in vitro.

• Angiotensin I/II (1-5): Product Overview

  2026-10-09

  APExBIO lists Angiotensin I/II (1-5), SKU A1047, as an Asp-Arg-Val-Tyr-Ile peptide fragment for conceptual renin-angiotensin system research. No matched paper evidence is available for product-specific performance or outcomes.

• DOPE in LNP Design: Fusion, Evidence, and Limits

  2026-10-09

  Explore how 1,2-Dioleoyl-sn-glycero-3-PE (DOPE) influences membrane packing, endosomal escape, and nucleic acid delivery. This evidence-led analysis also distinguishes established DOPE mechanisms from emerging zwitterionic lipid research in mRNA cancer vaccines.

• FAM134B, ER-Phagy, and Salmonella Infection

  2026-10-08

  A 2025 Nature Communications study identifies the ER-phagy receptor FAM134B as a host defense factor targeted by Salmonella Typhimurium through the bacterial effector SopF. Genetic, cellular, and mouse-model evidence supports a mechanism in which impaired FAM134B oligomerization suppresses ER-phagy and increases intracellular bacterial burden, while also highlighting important limits on how broadly the findings can be generalized.

• Amikacin Disulfate: Mechanism and Evidence

  2026-10-08

  Amikacin disulfate is a semisynthetic aminoglycoside antibiotic used to study 16S rRNA recognition, bacterial protein synthesis suppression, and resistance biology. Peer-reviewed evidence also shows amikacin can form complexes with lysozyme, but that finding does not establish bacterial efficacy or clinical performance.

• Carvedilol: β-Blockade and HCT Regeneration

  2026-10-07

  Carvedilol is a nonselective β-adrenergic receptor antagonist with α1-adrenergic activity. A 2025 mouse-to-human study associated nonselective β-blockade with impaired hematopoietic regeneration after allogeneic transplantation, while leaving receptor-level causality unresolved.

• Cefiderocol Against Resistant Pseudomonas and Acinetobacter

  2026-10-07

  A large European surveillance study found that cefiderocol retained high in vitro activity against Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and several newer β-lactam/β-lactamase inhibitor combinations. The study’s value lies in its direct, contemporary comparison of resistance phenotypes and genomic findings, while its clinical implications remain bounded by the in vitro design.

• Gentamycin Sulfate in Resistance Research

  2026-10-06

  A translational perspective on Gentamycin Sulfate as a mechanistic probe for bacterial protein synthesis research, ribosome function analysis, and the interpretation of resistance findings in Gram-negative pathogens.

• Neuroligin 1, Striatal D2-MSNs, and Repetitive Behavior

  2026-10-06

  A study in Advanced Science links Neuroligin 1 loss in dorsal-striatal D2 receptor-expressing medium spiny neurons to excessive self-grooming and digging in mice. Its combination of cell-type-specific behavioral analysis, neuronal activity measurements, single-nucleus RNA sequencing, and protein validation identifies PKC overactivation as a candidate molecular contributor while leaving important questions about isoform specificity and relevance to human autism.

• Five Questions About ATP Luminescence in Ferroptosis

  2026-10-05

  A source-grounded guide to what ATP-based luciferase luminescence measures, how it relates to ferroptosis research, and where evidence, interpretation, and applicability remain limited.

• Biotin-XX Tyramide Reagent for Surface Biology

  2026-10-05

  Biotin-XX Tyramide Reagent, also known as biotin-LC-LC-tyramide, offers a membrane-impermeant perspective on low-abundance surface molecules. This article explains how its chemistry can help interpret activity-dependent synaptic biology without confusing surface localization with total protein abundance.

• Cy5 Amine (Non-Sulfonated): Product Overview

  2026-10-04

  Cy5 amine (non-sulfonated), SKU A8143, is a supplier-described primary-amine cyanine dye for conceptual fluorescent biomolecule-labeling applications. No matched paper evidence is available for independent performance assessment.

• Angiotensin I/II (1-5): Product Overview

  2026-10-03

  APExBIO lists Angiotensin I/II (1-5) as an Asp-Arg-Val-Tyr-Ile peptide fragment for conceptual renin-angiotensin system research. No matched paper evidence was supplied, so biological performance and research outcomes are not independently established here.

• CLCC1 and Herpesvirus Nuclear Egress Fusion

  2026-10-02

  This preprint identifies the host protein CLCC1 as an essential factor in the membrane-fusion step of herpesvirus nuclear egress. A whole-genome CRISPR screen with HSV-1, combined with cellular and evolutionary analyses, links CLCC1 loss to perinuclear capsid accumulation, reduced viral production, and defective nuclear pore insertion.

8136 records 1/543 page Next 12345 下5页 Last page